Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Pharmaceutical Executive September 1, 2012 Roy F. Waldron	Open Innovation in Pharma: Defining the Dialogue There is much talk today about "open innovation" in business and research forums, but what exactly does it mean? How does open innovation as a concept apply to the pharmaceutical sector?
Chemistry World January 2007 Yfke Hager	Careers: Spin-Out Sense Craig Banks is passionate about his chemistry research. In his short academic career he has already co-founded a spin-out firm to make cannabis detectors.
Chemistry World May 25, 2007 Richard Van Noorden	Keeping it Green Some chemistry enthusiastically labeled as green may be nothing of the kind, warn researchers who worry that mediocre -- if well-meaning -- science is damaging their subject.
Chemistry World October 12, 2011 Joanne Thomson	Hot Chemistry Temperature played a crucial role in David MacMillan's decision to study chemistry.
Chemistry World March 2011 Bea Perks	Editorial: At the forefront The news that most of Pfizer's 2400 employees at Sandwich, U.K. will be made redundant over the next two years was met with surprise, disappointment and anger.
Chemistry World July 2008 Kevin Rogers	What future for small molecule therapy? Pharmaceutical companies overlook bench chemists at their peril
Chemistry World March 6, 2013 Jon Evans	Data challenges for UK chemists Academic chemists in the UK have a problem with data. That's the claim made by a report that says that both in terms of managing and sharing data produced by their own laboratories and accessing data produced by others, chemists are all at sea.
Chemistry World September 2007 Ian Pearson	Comment: Global Science Matters The UK's new science minister says that an international perspective is vital for scientific growth.
Chemistry World September 2009	Education and wealth It seems that the UK government is interested in answering the question: what return does the UK get for the money it puts into academic research in chemistry?
Chemistry World July 9, 2008 James Mitchell Crow	Pharma goes green to cut costs The pharmaceutical industry's current drive to curb spending is helping to speed the adoption of green chemistry, say experts in the industry.
The Motley Fool June 20, 2011 Luke Timmerman	Pfizer's Idea to Fix the Drug Development Crisis, Which Probably Won't Work (But Just Might) In a worst-case scenario, Pfizer flushes a few hundred million dollars down the tubes. What's the best-case scenario?
Chemistry World July 2006	Careers: Work, Rest and Play A thirst for new challenges led chemist Marek Klunduk into a scientific career with the petfood division of Mars.
Chemistry World September 17, 2013 Laura Howes	What happens when you perturb the system? David Smith is a professor of chemistry at the University of York in the UK. His research explores how supramolecular chemistry can make molecular-scale building blocks self-assemble into nanostructures. He also has a passion for educational outreach.
Chemistry World March 23, 2006 Bea Perks	Boost for Chemical Innovation A boost in innovative performance across the UK was promised at yesterday's launch of the Chemistry Innovation Knowledge Transfer Network, which plans to offer companies a single point of access to carefully selected experts and organizations.
The Motley Fool January 31, 2011 Brian Orelli	Pharma Goes Back to School But will it produce more drugs? The pharmaceutical industry is headed back to school, with a number of large drugmakers announcing partnerships with universities.
Pharmaceutical Executive June 1, 2011	Emerging Pharma Leaders 2011 Meet 2011's Emerging Pharma Leaders. Can these 30 trendsetters build competitive scale from scarcity?
Chemistry World August 13, 2015	Exploiting the data mine Chemists must embrace open data to allow us to collectively get the best out of the masses of new knowledge we unearth, reports Clare Sansom
Pharmaceutical Executive September 1, 2011 Richard Barker	Innovating Around Innovation The former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Pharmaceutical Executive October 1, 2005 Mark J. Ahn	It's All Academic: Biotechs Looking to Universities Pharmaceuticals and academic institutions are forming alliances at an increasing rate to exploit the promise of emerging biological insights.
Bio-IT World December 10, 2002 Malorye Branca	The Trouble with Pharmaceutical Innovation There's a lot of one kind, but not enough of another in pharma land. Too many new technologies and too few new drugs -- that sums up the state of pharmaceutical R&D.
Chemistry World July 18, 2011 Patrick Walter	UK chemistry threatened by funding squeeze Chemistry in the UK is in danger of falling behind its international competitors as a result of a squeeze on funding for vital lab equipment, according to chemistry department heads.
Chemistry World May 9, 2008 Richard Van Noorden	Blueprint for 1bn UK technology drive unveiled The UK's Technology Strategy Board (TSB) has outlined how it will invest 1 billion over the next three years to boost innovative R&D and business.
Chemistry World March 22, 2012 Andrew Turley	GSK to build 350 million factory in UK GlaxoSmithKline has announced plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria.
Chemistry World September 2008 Derek Lowe	Column: In the pipeline The author remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
Chemistry World March 4, 2013 Andy Extance	UK considers patent rule change for trials The UK has announced plans to amend aspects of its patent law that may be encouraging pharma companies to run their clinical trials in other countries.
Reactive Reports December 2006 David Bradley	Dick Wife An interview with the chemical IT scientist and co-founder of SORD, a scientific publishing company that seeks to solve the problem of organizing the myriad of undocumented chemistry and the chaotic mess of the commercial database.
Chemistry World January 2012	Rising interest in compound bank David Fox argues for the creation of a centralized repository for small molecules to harness research efforts in drug discovery
Chemistry World April 21, 2009 Matt Wilkinson	Survival of the fittest While the pharmaceutical and biopharmaceutical sectors in general are outperforming broader stock market trends, many early stage companies are desperately trying to conserve cash and raise money to keep going.
Chemistry World August 2007 Derek Lowe	Opinion: In the Pipeline Process chemists just don't get the credit they deserve.
Chemistry World February 2007 Mark Peplow	Science Stars Rise in the East Collaborate or die. That's the message of a series of reports from the independent thinktank Demos, claiming that British science is in danger of being sidelined unless it tries harder to work with booming Asian nations such as China, India and South Korea.
Pharmaceutical Executive December 1, 2010 Zhu Shen	China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda
Pharmaceutical Executive January 21, 2014 Tim Powell	Innovation: The Moneyball Test Successful innovation now has to align with key metrics of value; can an old baseball metaphor help guide the way?
Chemistry World March 8, 2011 Andy Extance	GSK will pay off UK graduate tuition fees Potential undergraduate chemistry students concerned about their prospects in the face of plant closures and increased tuition fees have been given some cheer by pharmaceutical giant GlaxoSmithKline.
Chemistry World May 25, 2011 Sarah Houlton	Cost-cutting will stifle UK innovation The UK government's cost-cutting policies are in danger of stifling innovation, according to a report from The Work Foundation.
HHMI Bulletin Nov 2011 Sarah C.P. Williams.	Carolyn Bertozzi: Changed Expectations Chemists trained in biology were once a rarity -- now they're becoming the norm.
Pharmaceutical Executive November 1, 2011 Josef Bossart	Pharma Revolution Recalibrated Industry critics point to a lag in NME approvals as proof of innovation stagnation, but combination products and new delivery systems are quietly saving lives, and bringing in big dollars.
Chemistry World December 4, 2012 Andrew Turley	Drug R&D costs rising Inventing a new drug costs an enormous amount of money. It's part of the reason why the pharma industry is struggling to fill its pipelines. But we'd like to think that -- however slowly -- that cost is coming down. Unfortunately it isn't.
Pharmaceutical Executive January 1, 2012 Bill Drummy	Scared to Death The pharma industry's risk-aversion is risking its survival. Where did the courage to innovate go?
Chemistry World April 30, 2015 Simon Rushworth	Flexible, faster formulation The chemical using industries are a prime example of a sector where manufacturing must adopt new technologies to grow.
Chemistry World June 11, 2008 James Mitchell Crow	GSK Job Cuts Hit Chemists GlaxoSmithKline is cutting the jobs of hundreds of scientists as it restructures its drug R&D operations.
CRM June 24, 2011 Elisa O'Donnell	Kill the Office of Innovation What it really takes to create a thriving innovation capacity within an organization.
The Motley Fool September 21, 2006 Jack Uldrich	Harris & Harris Looks to Separate New technology could lead to safer, more effective drugs. Because of proprietary reasons, it's unlikely that ENS will be able to publicly announce when Big Pharma companies have licensed its technology, but Harris & Harris investors have reason to be optimistic.
Pharmaceutical Executive August 1, 2011 William Looney	Innovation at Pfizer A Q and A with Kristin Peck, the drug maker's Executive Vice President, Worldwide Business Development and Innovation.
Bio-IT World January 21, 2005 Jim Golden	Top 10 Trends for 2005 Pharmacovigilance, compliance, outsourcing, and the CIO's role will be big this year.
Chemistry World December 14, 2012 Rebecca Trager	US urged to rethink chemistry graduate education US chemistry graduate education needs an overhaul to address a possible glut of chemistry PhDs and other obstacles, according to a new report released by the American Chemical Society.
BusinessWeek August 27, 2009	Companies That Are Opening Up with Collaborative Research These three companies are examples of the new collaborative efforts taken to spur innovation.
Chemistry World June 12, 2009 Phillip Broadwith	UK chemists must take control The Engineering and physical sciences research council second international review of UK chemistry has warned that too little is being done to support early-career researchers and encourage high-risk research.
Chemistry World December 17, 2010	Lights, camera, action An interview with chemist Martyn Poliakoff, who is research professor of chemistry at the University of Nottingham in the UK. His main research interest is the application of supercritical fluids with a focus on green and sustainable chemistry. He is one of the
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.